| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Dorsey Brian serves as a Chief Operating Officer at SPRY. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $7K at current prices.
Historically, Dorsey Brian's trades have earned a middling insider score of 57/100 across 5 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +2.1%.
The biggest single holding is SPRY (~$7K) as Chief Operating Officer. The recent filings there lean toward selling, a net 141,828 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | SPRY Ars Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 21,828 | $8.71 | $190,049.85 | -66.9% | +13.0% | - | |
| Dec 12, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 40,000 | $12.35 | $493,858.50 | -86.9% | -2.6% | -19.0% | |
| Aug 20, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 50,000 | $15.00 | $750,000.00 | -89.2% | -7.5% | -1.9% | |
| Aug 13, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 30,000 | $13.00 | $390,000.00 | -83.3% | +33.9% | +21.1% |